Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Debt / NOTE 1.750% 6/1
-
Market price (% of par)
-
85.18%
-
Total 13F principal
-
$327,177,641
-
Principal change
-
+$8,580,053
-
Total reported market value
-
$278,394,000
-
Number of holders
-
40
-
Value change
-
+$6,971,026
-
Number of buys
-
16
-
Number of sells
-
15
Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 as of Q4 2017
As of 31 Dec 2017,
ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 was held by
40 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$327,177,641
in principal (par value) of the bond.
The largest 10 bondholders included
BAKER BROS. ADVISORS LP, CNH PARTNERS LLC, CITADEL ADVISORS LLC, CANYON CAPITAL ADVISORS LLC, Partner Fund Management, L.P., Davidson Kempner Capital Management LP, WOLVERINE ASSET MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP, AMERIPRISE FINANCIAL INC, and JPMORGAN CHASE & CO.
This page lists
41
institutional bondholders reporting positions
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.